Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,264,994 papers from all fields of science
Search
Sign In
Create Free Account
Raynaud Disease
Known as:
Raynauds Disease
, raynauds
, disease raynaud
Expand
An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
31 relations
Narrower (2)
Angiopathy, Hereditary, With Nephropathy, Aneurysms, And Muscle Cramps
Raynaud Phenomenon
Broader (3)
Arterial Occlusive Diseases
Cardiovascular Diseases
Peripheral Vascular Diseases
Captopril
Cold Sensation
Cold intolerance
Finger Injuries
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1996
1996
Possible Erythromelalgia-Like Syndrome Associated with Nifedipine in a Patient with Raynaud's Phenomenon
J. F. Sunahara
,
M. L. Gora-Harper
,
K. Nash
The Annals of Pharmacotherapy
1996
Corpus ID: 35110678
OBJECTIVE: TO describe a patient who was diagnosed with Raynaud's phenomenon, was prescribed immediate-release nifedipine, and…
Expand
1987
1987
Nicardipine in the treatment of Raynaud's phenomenon. Dissociation of platelet activation from vasospasm.
F. Wigley
,
R. Wise
,
R. Malamet
,
T. E. Scott
Arthritis & Rheumatism
1987
Corpus ID: 34001348
A new calcium channel blocker, nicardipine, was studied for treatment of Raynaud's phenomenon in a double-blind, placebo…
Expand
1985
1985
A double blind placebo controlled crossover randomized trial of diltiazem in Raynaud's phenomenon.
A. Rhedda
,
J. Mccans
,
A. Willan
,
P. Ford
Journal of Rheumatology
1985
Corpus ID: 26507730
We report the results of a double blind placebo controlled crossover randomized study of the calcium channel blocking agent…
Expand
Highly Cited
1982
Highly Cited
1982
Cutaneous and subcutaneous inflammatory sclerosis syndromes.
J. Doyle
,
S. Connolly
,
R. Winkelmann
Archives of Dermatology
1982
Corpus ID: 35209390
Systemic scleroderma and localized scleroderma (morphea) show comparable changes on skin biopsy specimens, and a distinction has…
Expand
1981
1981
Biofeedback treatment of Raynaud's disease and phenomenon
R. Freedman
,
S. Lynn
,
P. Ianni
,
P. Hale
Biofeedback and Self-Regulation
1981
Corpus ID: 38727945
Six Raynaud's disease and four Raynaud's phenomenon patients were treated with 12 sessions of finger temperature biofeedback. The…
Expand
Highly Cited
1975
Highly Cited
1975
The diagnosis and treatment of Raynaud's phenomenon.
J. Porter
,
R. L. Snider
,
E. Bardana
,
J. Rösch*
,
L. Eidemiller
Surgery
1975
Corpus ID: 30443908
Twenty-five patients with Raynaud's phenomenon, including 20 with associated diseases and five with primary Raynaud's disease…
Expand
Review
1970
Review
1970
Medical aspects of oral contraceptives.
N. Elgee
Annals of Internal Medicine
1970
Corpus ID: 41594804
Medical and laboratory evaluations of oral contraceptives containing estrogen and progesterone singularly or in combination show…
Expand
1956
1956
Adsorption of tetanus toxin by brain tissue
A. J. Fulthorpe
Journal of Hygiene
1956
Corpus ID: 7740858
The potency of tetanus toxin as measured by combining power is markedly reduced by mixing with fresh or dried preparations of…
Expand
1947
1947
A Study of Portable Vibrating Tools in Relation to the Clinical Effects which they Produce
J. Agate
,
H. A. Druett
British Journal of Industrial Medicine
1947
Corpus ID: 10599714
working at right angles to the long axis of the tool. It worked at 4,500 b.p.m. The left hand would be expected to undergo most…
Expand
1943
1943
COLD HEMAGGLUTINATION WITH SYMMETRIC GANGRENE OF THE TIPS OF THE EXTREMITIES: REPORT OF A CASE
D. Stats
,
J. Bullowa
1943
Corpus ID: 71430996
The antigen-antibody reaction between human erythrocytes and serum in which hemagglutination is observed only at low temperatures…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE